CN Stock MarketDetailed Quotes

300558 Betta Pharmaceuticals

Watchlist
  • 55.22
  • +0.72+1.32%
Market Closed Dec 20 15:00 CST
23.11BMarket Cap50.29P/E (TTM)

About Betta Pharmaceuticals Company

Established in 2003, the company is a high-tech pharmaceutical enterprise founded by a team of high-level talents returning from overseas, integrating R&D, production and marketing with independent intellectual property research and development as the core. On November 7, 2016, Betta Pharmaceuticals was listed on the Shenzhen Stock Exchange. The company is a national high-tech enterprise founded by Dr. Overseas Returning, with research and development of innovative drugs with independent intellectual property as the core, integrating R&D, production and marketing. The company's main products Kaimena, Bemena, Beantin, SEMENA, and Vomena are chemical pharmaceuticals. Corporate honors: Chairman Ding Lieming won the title of “Outstanding Person in the Overseas Chinese Community”; Gao Yaqin, the company's senior QC commissioner, won the National May 1st Labor Medal; Chairman Ding Lieming won the Zhejiang Science and Technology Significant Contribution Award; Beida Pharmaceutical won the first “Four Strong Provinces” leading enterprise in Zhejiang; Dr. Ding Lieming won the first “Global Zhejiang Gold Award”, etc.

Company Profile

Short Name-A贝达药业
Symbol-A300558
Company NameBetta Pharmaceuticals Co.,Ltd
Listing DateNov 7, 2016
Issue Price17.57
Shares Offered41.00M share(s)
FoundedJan 7, 2003
Legal Representativelieming ding
General Managerlieming ding
Secretarylingxi wu
Accounting FirmLixin Certified Public Accountants (Special General Partnership)
Securities Representativejianhao shen
Legal CounselGuo Hao Law Firm (Hangzhou)
Employees1883
Phone0571-89265665
Office AddressNo. 355, Xingzhong Road, Yuhang Economic and Technological Development Zone, Hangzhou
Zip Code311100
Registered AddressNo. 355, Xingzhong Road, Yuhang Economic and Technological Development Zone, Hangzhou, Zhejiang
Fax0571-89265665
Emailbetta0107@bettapharma.com
Business License330100400024187
BusinessPharmaceutical production; pharmaceutical wholesale; drug retail; drug import/export (projects requiring approval according to law can only be carried out business activities after approval by relevant departments; specific business projects are subject to approval results). Technical services, technology development, technical consultation, technology exchange, technology transfer, and technology promotion (except for projects subject to approval according to law, independently carry out business activities based on a business license in accordance with law).

Company Executives

  • Name
  • Position
  • Salary
  • lieming ding
  • Chairman, Directors, General Manager, CEOs, Nomination Committee Members, Strategy Committee Convener
  • 2.90M
  • tian xu
  • Directors, Member of the Remuneration and Assessment Committee
  • --
  • shizhe ding
  • Directors
  • --
  • jiang wan
  • Directors, Senior Vice President, Strategy Committee Member, Chief Operating Officer
  • 2.55M
  • zhihua yu
  • Directors, Audit Committee Member
  • --
  • jia tong
  • Directors, CEO, Strategy Committee Member
  • 1.46M
  • jianxun fan
  • Directors, VP, Chief Financial Officer, Strategy Committee Member
  • 1.46M
  • JIANGNAN CAI
  • Independent Directors, Remuneration and Assessment Committee Convener, Nomination Committee Members
  • 120.00K
  • wei wang
  • Independent Directors, Audit Committee Member, Member of the Remuneration and Assessment Committee
  • 120.00K
  • jiajia xiao
  • Independent Directors, Audit Committee Member, Nomination Committee Convener
  • 120.00K
  • xinqi huang
  • Independent Directors, Member of the Remuneration and Assessment Committee, Audit Committee Convener
  • 120.00K
  • lingxi wu
  • Board Secretary, Head of the Internal Audit Department
  • 995.60K
  • jianhao shen
  • Securities Affairs Representative
  • --
  • yangnan zhang
  • Chairman of the Supervisory Board, Auditors
  • 870.70K
  • rong wang
  • Auditors
  • --
  • fei wu
  • Employee Supervisors
  • 860.20K